Oriola Oyj (FRA:O5O)

Market Cap	177.09M -16.2%
Revenue (ttm)	1.91B +13.4%
Net Income	-27.20M
EPS	-0.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	8.01
Dividend	0.03 (3.16%)
Ex-Dividend Date	Mar 26, 2026

Volume	n/a
Average Volume	143
Open	0.9490
Previous Close	0.9670
Day's Range	0.9490 - 0.9490
52-Week Range	0.9490 - 1.2400
Beta	n/a
RSI	26.83
Earnings Date	Apr 29, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1907
• Employees: 869
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: O5O

Financial Performance

In 2025, Oriola Oyj's revenue was 1.91 billion, an increase of 13.40% compared to the previous year's 1.68 billion. Losses were -27.20 million, 35.3% more than in 2024.